TSXV/TLT (TSXV/TLT)

TSX Venture Exchange: TSXV/TLT · CAD

CA$0.20

+0.00 (0.0%)· Recorded snapshot

Market cap	62.1M
Revenue (ttm)	802.5K
Net income (ttm)	-3.8M
EPS (ttm)	-CA$0.01
Shares out	310.5M
P/E (forward)	40.0x
Volume	39,890
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 802.5K
Net income (ttm): -3.8M
EPS (ttm): -CA$0.01
P/E (forward): 40.0x
Market cap: 62.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E40

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-93.4

P25 n/aP50 n/aP75 n/a

ROIC-55.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/TLT indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

CAD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Employees	20
Employees change	-14
Employees growth	-41.18%
Enterprise value	CAD 57M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Medical Devices
Is primary listing	Yes
ISIN number	CA88337V1004
Last earnings date	2025-11-28
Last refreshed	2026-10-28
Market cap	CAD 62.1M
Next earnings date	2026-11-27
Price	CAD 0.20
Price currency	CAD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	tsxv/TLT
Website	https://www.theralase.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7.12%
EV/Sales	71.01x
FCF / EV yield	-5.91%
FCF yield	-5.42%
Forward P/E	40x
P/B ratio	9.08x
P/S ratio	77.38x
Price / tangible book value	9.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	65.44%
Operating margin	-474.33%
Pretax margin	-472.48%
Profit per employee	CAD -189,575
Revenue per employee	CAD 40,123
ROA	-42.7%
ROA (5Y)	-67.41%
ROCE	-55.34%
ROE	-93.4%
ROE (5Y)	-160.35%
ROIC	-55.9%
SBC / revenue	49.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	3
Gross profit growth	-11.88%
Gross profit growth (Q)	-27.9%
Gross profit growth 3Y	-1.44%
Gross profit growth 5Y	6.68%
Net income growth years	3
Revenue growth	-24.86%
Revenue growth (Q)	-25.23%
Revenue growth (QoQ)	23.87%
Revenue growth 10Y	-9.43%
Revenue growth 3Y	-7.45%
Revenue growth 5Y	-5.52%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD 21,445
Depreciation and amortization	CAD 154,755
EBIT	CAD -3.8M
EBITDA	CAD -3.7M
EPS	CAD -0.01
FCF per share	CAD -0.01
Financing cash flow	CAD 8.6M
Free cash flow	CAD -3.4M
Free cash flow minus SBC	CAD -3.8M
Gross profit	CAD 525,110
Investing cash flow	CAD 25,067
Net borrowing	CAD 273,616
Net cash flow	CAD 5.2M
Net income	CAD -3.8M
Operating cash flow minus SBC	CAD -3.8M
Operating income	CAD -3.8M
Revenue	CAD 802,462
Stock-based compensation	CAD 395,699

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	15.28
Book value per share	CAD 0.02
Debt / equity	0.02
Interest coverage	-67.46
Long-term assets	CAD 1.3M
Long-term liabilities	CAD 36,162
Net cash (debt)	CAD 5.1M
Net cash / market cap	8.23%
Net debt / equity	-0.75
Piotroski F-Score	3
Property, plant and equipment	CAD 340,341
Shareholders' equity	CAD 6.8M
Tangible book value	CAD 6.8M
Tangible book value per share	CAD 0.02
Total assets	CAD 8.1M
Total cash	CAD 5.3M
Total debt	CAD 148,717
Total liabilities	CAD 1.3M
WACC	6.56%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.14
Current assets	CAD 6.8M
Current liabilities	CAD 1.2M
Current ratio	5.48
Inventory turnover	0.56
Net working capital	CAD 446,049
Quick ratio	4.89
Working capital	CAD 5.6M
Working capital turnover	0.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.24%
Shareholder yield	-7.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-48.05%
10Y return CAGR	-6.34%
10Y total return	-48.05%
150-day SMA	CAD 0.24
15Y price change	-54.55%
15Y return CAGR	-5.12%
15Y total return	-54.55%
1D price change	0%
1M price change	14.29%
1M total return	14.29%
1W price change	8.11%
1W total return	8.11%
20-day SMA	CAD 0.19
200-day SMA	CAD 0.25
20Y price change	-60%
20Y return CAGR	-4.48%
20Y total return	-60%
3M price change	-23.08%
3M total return	-23.08%
3Y price change	8.11%
3Y return CAGR	2.63%
3Y total return	8.11%
50-day SMA	CAD 0.19
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.41
52-week high date	2026-04-28
52-week low	CAD 0.15
52-week low date	2025-12-15
6M price change	-48.72%
6M total return	-48.72%
All-time high	CAD 2.80
All-time high date	1997-02-25
All-time low	CAD 0.03
All-time low date	2008-12-15
Average true range (ATR)	CAD 0.01
Average volume	127.3K
Beta (1Y)	-0.16
Beta (2Y)	-0.05
Beta (5Y)	0.41
Change from 52-week high	-51.22%
Change from 52-week low	37.93%
Change from all-time high	-92.86%
Change from all-time low	700%
Change from open	-2.44%
Day's gap	2.5%
Dollar volume	CAD 7,978
High price	CAD 0.21
Low price	CAD 0.20
Monthly RSI	47.36
Open price	CAD 0.21
Position in 52-week range	0%
Previous close	CAD 0.20
Price vs 150-day SMA	-14.93%
Price vs 20-day SMA	6.38%
Price vs 200-day SMA	-18.6%
Price vs 50-day SMA	7.93%
Relative volume	0.31
RSI	56.27
Sharpe ratio	0.33
Sharpe ratio (3Y)	0.36
Sharpe ratio (5Y)	0.38
Sortino ratio	0.57
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.7
Volume	39.9K
Weekly RSI	45.62
YTD price change	21.21%
YTD total return	21.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	291.3M
Shares change (QoQ)	7.08%
Shares change (YoY)	7.24%
Shares held by insiders	6.17%
Shares held by institutions	0.14%
Shares outstanding	310.5M

Deeper analysis on TSXV/TLT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/TLT report

Is a complete TSXV/TLT research report available?

No complete published report is available for tsxv/TLT (TSXV/TLT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/TLT (TSXV/TLT)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/TLT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/TLT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/TLT

Frequently asked questions